Tag: Cancer
Merck, Eisai’s Keytruda-Lenvima combo stonewalled in liver cancer after Roche’s first-in-class...
Tumor response data previously won Merck & Co. and partner Eisai an FDA breakthrough therapy designation for the combination of PD-1 star Keytruda and...
Merck’s Keytruda flops bladder cancer trial, giving Roche’s Tecentriq an open...
Merck & Co.’s Keytruda has several clinical wins under its belt that have led to a long list of FDA approvals. But it can’t...
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...
ASCO: Pfizer, Merck KGaA’s Bavencio posts win in rare gynecological cancer
Pfizer and Merck KGaA’s Bavencio is having itself an ASCO. In addition to putting up game-changing results in bladder cancer, it’s posted a win...
Funding roundup: GRAIL raises $390M for cancer liquid biopsy test
GRAIL, a startup developing a blood test to screen for multiple cancers, added another $390 million to its war chest. To date, the Menlo...
Roche’s Kadcyla wins NICE backing in early breast cancer use
Unlike its first U.K. reimbursement negotiations, Roche’s HER2 antibody-drug conjugate sailed through a new NHS funding review that now puts it in line for...
Incyte plans Phase III trial of blood cancer drug as potential...
A paper published last month suggested that one of the reasons behind severe Covid-19 disease might be cytokine storm, a kind of out-of-control immune...
Veran Medical introduces navigated catheter for lung cancer lesions
Veran Medical has introduced a new navigated catheter and two navigation software applications to help physicians diagnose and guide treatment of early-stage lung cancer...
